There was no approved Alzheimer's treatment for Sylvia Waller's late father, but she says the FDA approval of Leqembi offers hope to others.
It's in the pictures Sylvia Waller lays out on a table that she remembers the best times with her dad, James.
There was no approved Alzheimer's treatment for Waller's dad, but she says the FDA approval of Leqembi offers hope. A big concern is the price. Medicare will cover most of Leqembi's cost of more than $26,000 a year, but many patients will be on the hook for roughly $5,300. Fabian Consbruck is a clinical psychologist outside Denver who works closely with the Hispanic community. Part of his work is giving patients tests to help determine if they have dementia.
"Not only do they need to get a diagnosis, they need to get a referral back to the specialist, to their primary care doctor," Consbruck says."The provider has to be caught up on the medication and feel comfortable with that medication."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tony Bennett’s battle with Alzheimer’s: What to know about dementia and deathAfter singer Tony Bennett's death, several neurology experts shared with Fox News Digital what people should know about late-stage Alzheimer’s and its potentially fatal complications.
Read more »
UW study increases access to expensive Alzheimer's treatmentMore people will have access to a new treatment, called Lecanemab, for Alzheimer's -- thanks to a UW study that's getting underway.
Read more »
UW study increases access to expensive Alzheimer’s treatmentMore people will have access to a new treatment for Alzheimer’s — thanks to a UW study
Read more »
New Alzheimer's drug success 'was built on failures': Eisai execThe drug received full approval this month, opening the doors to Medicare payments and expanding access for Alzheimer's patients who qualify for the twice-monthly infusion treatment.
Read more »
Italian Study Shows How Espressos Keep Alzheimer's Protein Clumps In CheckThe key components of espresso coffee may protect against the protein clumping in the brain associated with Alzheimer's disease, a new study on laboratory samples shows, giving scientists an exciting new treatment avenue to explore.
Read more »